GH Research Analyst Ratings
ATAI Life Sciences Analyst Ratings
Alkermes, DaVita, Jabil, Ralph Lauren, Among Potential M&A Candidates - BofA
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $31 Price Target
NRX Pharmaceuticals Analyst Ratings
Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday
Incannex Healthcare GAAP EPS of -$0.29 Beats by $0.20
RFK and the 'MAHA Trade': Vaccine Makers Down, Psychedelic Shares up
GH Research Q3 2024 GAAP EPS $(0.23) Beats $(0.25) Estimate
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
Mind Medicine Analyst Ratings
Mind Medicine Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results.
Mind Medicine Q3 2024 GAAP EPS $(0.27) Beats $(0.28) Estimate
Mind Medicine GAAP EPS of -$0.27 Beats by $0.03
Massachusetts Psychedelics Legalization Initiative Poised to Fail
Alkermes Raised to Buy by Stifel on Increased Confidence for ALKS2680
Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
A Glimpse Into The Expert Outlook On Alkermes Through 9 Analysts
Top 3 Health Care Stocks You'll Regret Missing In November